Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the two groups WAD grades 2 and 3. by Anneli Peolsson (7867601)

Subjects:

Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the neck-specific exercise with internet support (NSEIT) group and t... by Anneli Peolsson (7867601)

Subjects:

Pairwise comparisons of the intervention effects by time point for physiological parameters. by Vanessa Wellauer (18408477)

Subjects:

Pairwise comparisons of the intervention effects by time point for recovery parameter. by Vanessa Wellauer (18408477)

Subjects:

Table 6 - Gain and loss: Human and environmental wellbeing – drivers of Kilimanjaro’s decreasing biodiversity by Andreas Hemp (730415)

Comparison of body weight gain between control group and cigarette smoke exposed group mice. by Yue He (385239)

Subjects:

Scaling of overall health burden with yearly expenditure growth. by Margherita Molaro (17803989)

Subjects:

Impact on different areas of health. by Margherita Molaro (17803989)

Subjects:

(A) Thermocouple positions for the MIPS and MONO systems. (B) Preparation of bone cubes from fresh cow tibias further employed for ex vivo mechanical evaluation, osteotomy and bone... by Marsel Ganeyev (21453399)

Subjects:

Comparison of S-parameter and gain simulation of antennas. by Wen-Ying Zhou (10049543)

Study selection criteria. by Filip Stanicic (17808254)

Subjects:

PICOS criteria for the SLR. by Filip Stanicic (17808254)

Subjects:

PRISMA flow chart. by Filip Stanicic (17808254)

Subjects:

Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

Sampling point (Source: by Yonggang Huang (223155)

Placebo test. by Le Zhu (1771669)

Subjects:

Negative ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

Positive ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)